Protocol No.: A051901

Title
Phase I Trial of Methotrexate, Rituximab, Lenalidomide, and Nivolumab (NIVO-MR2) Induction followed by Lenalidomide and Nivolumab Maintenance in Primary CNS Lymphoma
Principal Investigator
Aulakh, Sonikpreet
Phase
I
Age Group
Adult
Applicable Disease Sites
Brain Cancer
Lymphoma
Participating Institution
Mary Babb Randolph Cancer Center
Contact
Nina Moore, RN
Research Specialist
Phone: +1 304-293-2991

View on ClinicalTrials.gov